← Leaderboards
Jeffrey Lennox
Emory University
$30,661,826
Attributed
$47,081,107
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$47,081,107 · 17
By mechanism
UM1$30,934,128 · 1
U01$13,908,131 · 1
P30$1,937,554 · 2
P51$217,237 · 2
M01$84,057 · 10
P01$0 · 1
Top collaborators
- Carlos Del Rio10 shared
- Mark Joseph Mulligan5 shared
Most similar at Emory University
Same institution · by research overlap
- Raymond F. Schinazi$18,319,973
- Benjamin A Lopman$5,420,824
- Saad B. Omer$12,253,271
- James J Kohler$591,006
- Samantha K Winskell$6,642,484
Others in their field
Top investigators on “Universities”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$507,483,583
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$463,124,587
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
UniversitiesAreaClinical ResearchMinorityResearch PersonnelSiteFundingVaccinesAids Clinical Trial GroupClinical TrialsEpidemicAids/Hiv ProblemClinicAdultWomanResourcesFacultyHiv InfectionsReportingPrincipal InvestigatorClinical Trials UnitMicrobicideUnited StatesCountry
Grant awards (41)
Emory-CDC CTU$3,165,957
UM1 · FY2022 · AI · contact PI
Emory-CDC CTU$3,134,849
UM1 · FY2021 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$4,795,200
UM1 · FY2020 · AI · contact PI
CTU COVID Testing Supplement$599,941
UM1 · FY2020 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$5,493,765
UM1 · FY2019 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,783,692
UM1 · FY2018 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,403,962
UM1 · FY2017 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,052,913
UM1 · FY2016 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$1,977,185
UM1 · FY2015 · AI · contact PI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit$2,518,885
UM1 · FY2014 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$55,671
UM1 · FY2013 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$1,952,108
UM1 · FY2012 · AI · contact PI
Clinical Core$407,495
P30 · FY2012 · AI · contact PI
Clinical Research$295,578
P30 · FY2011 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$1
U01 · FY2011 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$1,235,948
U01 · FY2010 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$499,534
U01 · FY2010 · AI · contact PI
Clinical Research$326,052
P30 · FY2010 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$4,827,520
U01 · FY2009 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$2,871,438
U01 · FY2009 · AI · contact PI
Clinical Research$337,341
P30 · FY2009 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$3,252,959
U01 · FY2008 · AI · contact PI
Clinical Research$293,167
P30 · FY2008 · AI · contact PI
Emory HIV/AIDS Clinical Trials Unit$1,220,731
U01 · FY2007 · AI · contact PI
Clinical Research$277,921
P30 · FY2007 · AI · contact PI
ACTG A5202: HIV IN NEWLY INFECTED SUBJECTS$42,286
M01 · FY2007 · RR · contact PI
A5210: PHASE IB/IIA DOSE-FINDING SAFETY AND ACTIVITY STUDY OF AMD11070$13,815
M01 · FY2007 · RR · contact PI
ACTG A5001: ALLRT$12,978
M01 · FY2007 · RR · contact PI
ACTG 362$6,280
M01 · FY2007 · RR · contact PI
ACTG A5164$3,351
M01 · FY2007 · RR · contact PI
ACTG A5157$1,674
M01 · FY2007 · RR · contact PI
ACTG A5146$419
M01 · FY2007 · RR · contact PI
ACTG A5142$419
M01 · FY2007 · RR · contact PI
ACTG A5211$419
M01 · FY2007 · RR · contact PI
PROJECT 3: CLINICAL TRIALS$59,665
P51 · FY2006 · RR · contact PI
PROJECT 3: CLINICAL TRIALS$54,536
P51 · FY2005 · RR
EFAVIRENZ, NEVIRAPINE, NEVIRAPINE, AND LOPINAVIR/RITONAVIR IN HIV DIALYSIS$2,416
M01 · FY2005 · RR
PROJECT 3: VACCINE DEVELOPMENT$53,772
P51 · FY2004 · RR
PROJECT 3: CLINICAL TRIALS$49,264
P51 · FY2003 · RR
Clinical trials$0
P01 · FY2002 · AI
Clinical trials$0
P01 · FY2001 · AI